Sign In
Buy AVNS
$24.98
-0.0150 (-0.0600%)
At Close: Jun 03, 2026
Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-Markers Medical
04:15pm, Thursday, 31'st Jul 2025
ALPHARETTA, Ga. , July 31, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), announced today the divestiture of its Hyaluronic Acid (HA) product line to Channel-Markers Medical, LLC (CMM), a pr
Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2025 Financial Results
10:20am, Thursday, 24'th Jul 2025
ALPHARETTA, Ga. , July 24, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2025 on
New Strong Sell Stocks for July 15th
06:26am, Tuesday, 15'th Jul 2025
DDD, AVNS and BABA have been added to the Zacks Rank #5 (Strong Sell) List on July 15, 2025.
Avanos Medical, Inc. Welcomes Camille Chang Gilmore as Senior Vice President and Chief Human Resources Officer
07:15am, Monday, 09'th Jun 2025
ALPHARETTA, Ga. , June 9, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) a leading medical technology company focused on delivered innovative healthcare solutions, today announced the appoint
Avanos Medical (AVNS) International Revenue in Focus: Trends and Expectations
10:22am, Tuesday, 13'th May 2025
Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
New Strong Sell Stocks for May 9th
07:55am, Friday, 09'th May 2025
AVNS, BCC and AMPY have been added to the Zacks Rank #5 (Strong Sell) List on May 9, 2025.
AVNS Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down
01:50pm, Wednesday, 07'th May 2025
Strength in Avanos' SNS segment drives its first-quarter 2025 performance despite global macroeconomic challenges.
Avanos Medical, Inc. (AVNS) Q1 2025 Earnings Call Transcript
02:38pm, Tuesday, 06'th May 2025
Avanos Medical, Inc. (NYSE:AVNS ) Q1 2025 Earnings Conference Call May 6, 2025 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy and Corporate Development Dave Pacitti - Chief
Avanos Medical (AVNS) Q1 Earnings and Revenues Top Estimates
09:25am, Tuesday, 06'th May 2025
Avanos Medical (AVNS) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.22 per share a year ago.
Avanos Medical, Inc. Announces First Quarter 2025 Results
07:00am, Tuesday, 06'th May 2025
ALPHARETTA, Ga. , May 6, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2025 financial results.
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results
07:47am, Monday, 28'th Apr 2025
ALPHARETTA, Ga. , April 28, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2025 on�
AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK
08:55am, Thursday, 03'rd Apr 2025
Avanos takes direct control of MIC-KEY sales in the UK, enhancing market presence, customer engagement and service efficiency, starting July 2025.
Avanos Expands Direct Operations for MIC-KEY* Enteral Feeding Products in the UK starting July 2025
07:00am, Wednesday, 02'nd Apr 2025
ZAVENTEM, Belgium , April 2, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) a global medical technology company, today announced that it will take direct responsibility for the sales and distr
New Strong Sell Stocks for March 24th
06:30am, Monday, 24'th Mar 2025
AVNS, AIRS and AMPH have been added to the Zacks Rank #5 (Strong Sell) List on March 24, 2025.
New Strong Sell Stocks for March 18th
09:00am, Tuesday, 18'th Mar 2025
AVNS, CARS and CABO have been added to the Zacks Rank #5 (Strong Sell) List on March 18, 2025.
